Co-Authors
This is a "connection" page, showing publications co-authored by FLORIAN MULLER and STEVEN MILLWARD.
Connection Strength
0.877
-
Comparative Pharmacology of a Bis-Pivaloyloxymethyl Phosphonate Prodrug Inhibitor of Enolase after Oral and Parenteral Administration. ACS Pharmacol Transl Sci. 2023 Feb 10; 6(2):245-252.
Score: 0.218
-
Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of ENO1-Deleted Cancers. J Med Chem. 2022 10 27; 65(20):13813-13832.
Score: 0.215
-
Quantification of Phosphonate Drugs by 1H-31P HSQC Shows That Rats Are Better Models of Primate Drug Exposure than Mice. Anal Chem. 2022 07 19; 94(28):10045-10053.
Score: 0.210
-
Enolase inhibitors as therapeutic leads for Naegleria fowleri infection. PLoS Pathog. 2024 Aug; 20(8):e1012412.
Score: 0.061
-
Enolase inhibitors as therapeutic leads for Naegleria fowleri infection. bioRxiv. 2024 Jan 17.
Score: 0.058
-
Enolase Inhibitors as Early Lead Therapeutics against Trypanosoma brucei. Pathogens. 2023 Oct 28; 12(11).
Score: 0.058
-
Anaplerotic nutrient stress drives synergy of angiogenesis inhibitors with therapeutics targeting tumor metabolism. bioRxiv. 2023 Oct 19.
Score: 0.057